HALOZYME THERAPEUTICS INC's ticker is and the CUSIP is 40637H959. A total of 4 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $370,540 | -4.0% | 9,700 | -9.3% | 0.00% | 0.0% |
| Q2 2023 | $385,949 | +0.1% | 10,700 | +5.9% | 0.00% | 0.0% |
| Q1 2023 | $385,719 | -79.0% | 10,100 | -68.7% | 0.00% | -75.0% |
| Q4 2022 | $1,837,870 | +383.6% | 32,300 | +236.5% | 0.00% | +300.0% |
| Q3 2022 | $380,000 | -10.0% | 9,600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $422,000 | -17.9% | 9,600 | -25.6% | 0.00% | 0.0% |
| Q1 2022 | $514,000 | -26.6% | 12,900 | -25.9% | 0.00% | 0.0% |
| Q4 2021 | $700,000 | -14.8% | 17,400 | -13.9% | 0.00% | 0.0% |
| Q3 2021 | $822,000 | -25.2% | 20,200 | -16.5% | 0.00% | 0.0% |
| Q2 2021 | $1,099,000 | -0.2% | 24,200 | -8.3% | 0.00% | -50.0% |
| Q1 2021 | $1,101,000 | +303.3% | 26,400 | +312.5% | 0.00% | – |
| Q4 2020 | $273,000 | +167.6% | 6,400 | +64.1% | 0.00% | – |
| Q3 2020 | $102,000 | -4.7% | 3,900 | -2.5% | 0.00% | – |
| Q2 2020 | $107,000 | +98.1% | 4,000 | +33.3% | 0.00% | – |
| Q1 2020 | $54,000 | -87.9% | 3,000 | -88.0% | 0.00% | -100.0% |
| Q4 2019 | $445,000 | -1.1% | 25,100 | -13.4% | 0.00% | -25.0% |
| Q3 2019 | $450,000 | -12.5% | 29,000 | -3.0% | 0.00% | -20.0% |
| Q2 2019 | $514,000 | -47.4% | 29,900 | -50.7% | 0.01% | -54.5% |
| Q1 2019 | $977,000 | +20.8% | 60,700 | +9.8% | 0.01% | +57.1% |
| Q4 2018 | $809,000 | -21.2% | 55,300 | -2.1% | 0.01% | -12.5% |
| Q3 2018 | $1,027,000 | +29.2% | 56,500 | +20.0% | 0.01% | +14.3% |
| Q2 2018 | $795,000 | -29.1% | 47,100 | -17.7% | 0.01% | -36.4% |
| Q1 2018 | $1,121,000 | -60.4% | 57,200 | -59.1% | 0.01% | -45.0% |
| Q4 2017 | $2,834,000 | +0.2% | 139,900 | -14.1% | 0.02% | -23.1% |
| Q3 2017 | $2,828,000 | +68.0% | 162,800 | +24.0% | 0.03% | +52.9% |
| Q2 2017 | $1,683,000 | -42.3% | 131,300 | -41.7% | 0.02% | -50.0% |
| Q1 2017 | $2,919,000 | +209.5% | 225,200 | +136.1% | 0.03% | +277.8% |
| Q4 2016 | $943,000 | +15.0% | 95,400 | +40.5% | 0.01% | 0.0% |
| Q3 2016 | $820,000 | +42.6% | 67,900 | +2.0% | 0.01% | +28.6% |
| Q2 2016 | $575,000 | +25.3% | 66,600 | +37.3% | 0.01% | +16.7% |
| Q1 2016 | $459,000 | -91.5% | 48,500 | -84.4% | 0.01% | -90.6% |
| Q4 2015 | $5,390,000 | +13.3% | 311,000 | -12.2% | 0.06% | -3.0% |
| Q3 2015 | $4,756,000 | -26.5% | 354,100 | +23.6% | 0.07% | -27.5% |
| Q2 2015 | $6,471,000 | +261.1% | 286,600 | +128.4% | 0.09% | +225.0% |
| Q1 2015 | $1,792,000 | -37.0% | 125,500 | -57.4% | 0.03% | -34.9% |
| Q4 2014 | $2,846,000 | +131.8% | 294,900 | +118.6% | 0.04% | +126.3% |
| Q3 2014 | $1,228,000 | -14.0% | 134,900 | -6.6% | 0.02% | -13.6% |
| Q2 2014 | $1,428,000 | +24.6% | 144,500 | +60.2% | 0.02% | +15.8% |
| Q1 2014 | $1,146,000 | -50.2% | 90,200 | -41.2% | 0.02% | -45.7% |
| Q4 2013 | $2,299,000 | -47.1% | 153,400 | -61.1% | 0.04% | -57.8% |
| Q3 2013 | $4,349,000 | +152.1% | 393,900 | +81.5% | 0.08% | +93.0% |
| Q2 2013 | $1,725,000 | – | 217,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 10,100 | $385,719 | 0.00% |
| SIMPLEX TRADING, LLC | 4,500 | $171 | 0.00% |
| JANE STREET GROUP, LLC | 7,900 | $301,701 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |